Unknown

Dataset Information

Can hyperbaric oxygen safely serve as an anti-inflammatory treatment for COVID-19?


ABSTRACT:

Introduction

SARS-CoV-2 affects part of the innate immune response and activates an inflammatory cascade stimulating the release of cytokines and chemokines, particularly within the lung. Indeed, the inflammatory response during COVID-19 is likely the cause for the development of acute respiratory distress syndrome (ARDS). Patients with mild symptoms also show significant changes on pulmonary CT-scan suggestive of severe inflammatory involvement.

Hypothesis

The overall hypothesis is that HBO2 is safe and reduces the inflammatory response in COVID-19 pneumonitis by attenuation of the innate immune system, increase hypoxia tolerance and thereby prevent organ failure and reduce mortality.

Evaluation of the hypothesis

HBO2 is used in clinical practic

SUBMITTER: Kjellberg A 

PROVIDER: S-EPMC7456590 | biostudies-literature | 2020 Nov

REPOSITORIES: biostudies-literature